• Drugmaker: Antibody Prevents COVID in Nursing Home Patients

    1 month ago - By MedPageToday

    Bamlanivimab, the monoclonal antibody authorized to treat less-severe cases of COVID-19, reduced the risk of contracting symptomatic disease among nursing home residents and staff in the placebo-controlled BLAZE-2 trial, said...
    Read more ...

     

  • Drug Prevents Coronavirus Infection in Nursing Homes, Maker Claims

    Drug Prevents Coronavirus Infection in Nursing Homes, Maker Claims

    1 month ago - By NY Times

    A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
    Read more ...